Grevenbroich, Germany

Ulrich Borchard

This inventor holds 1 USPTO granted patent. Top assignee: Rohm Gmbh Chemische Fabrik. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Borchard. Retrieved from https://idiyas.com/inventor/ulrich-borchard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrich Borchard: Innovator in Pharmaceutical Preparations

Introduction

Ulrich Borchard is a notable inventor based in Grevenbroich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with cardiac activity. His work focuses on innovative solutions that address critical health issues.

Latest Patents

Borchard holds a patent for a compound known as 2,4,7-triamino-6-phenylpteridine. This invention relates to pharmaceutical preparations that exhibit cardiac, specifically anti-arrhythmic, activity. The active principle of this preparation includes at least one compound of a specific formula, where R represents a lipophilic radical. The pharmaceutical compositions may also include this compound alongside other pharmaceutical excipients and adjuvants.

Career Highlights

Ulrich Borchard is associated with Rohm GmbH Chemische Fabrik, where he has been instrumental in advancing pharmaceutical research. His expertise in the field has led to the development of innovative products that enhance cardiac health.

Collaborations

Borchard has collaborated with esteemed colleagues such as Karl-Dieter Voelger and Ernst Mutschler. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical development.

Conclusion

Ulrich Borchard's contributions to the pharmaceutical industry, particularly through his patent for 2,4,7-triamino-6-phenylpteridine, highlight his commitment to improving cardiac health. His work continues to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…